ICM
IRWD icon

Islay Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Islay Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,597
Closed -$78K – 296
2020
Q2 		$78K Sell
7,597
-884
-10% -$9.05K 0.09% 141
2020
Q1 		$86K Buy
+8,481
New +$99.7K 0.11% 98

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Islay Capital Management's IRWD Position: Q3 2020 in Review

Islay Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2020, closing a stake of 7,597 shares — an estimated $78K sold.

Islay Capital Management first reported a position in IRWD in Q1 2020 and held it in 2 quarters. The position peaked at $86K in Q1 2020. 190 funds tracked by Wall St. Rank hold IRWD as of Q3 2020.

  • Islay Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Islay Capital Management sold 7,597 Ironwood Pharmaceuticals shares in Q3 2020, an estimated $78K.
  • Islay Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2020 and held it in 2 quarters.
  • Islay Capital Management's Ironwood Pharmaceuticals position peaked at $86K in Q1 2020.
  • 190 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2020.

Based on Islay Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.